文献速递免疫规划卫生政策与健康促进

疫苗拒绝的社会成本:以麻疹疫苗接种为案例的模型研究

The societal cost of vaccine refusal: A modelling study using measles vaccination as a case study.
PubMed 文献 · Vaccine · 2023-05-30

BACKGROUND: Increasing vaccine hesitancy and refusal poses a challenge to public health as even small reductions in vaccine uptake can result in large outbreaks of infectious diseases. Here we estimate the societal costs of vaccine refusal using measles as a case study.…

要点

  • 高混合水平下,拒绝接种者受益于支持接种人群的群体免疫。
  • 拒绝接种增加已接种者(因疫苗不完美)和无法接种者的麻疹负担。

核心结论

  • 即使低水平的疫苗拒绝也可对人群造成重大且可测量的社会负担,这些估计可支持投资于解决疫苗犹豫和拒绝的干预措施,不仅改善公共卫生还可带来潜在经济收益。

研究设计与样本

  • 构建麻疹传播的隔室集合种群模型,探索“支持接种”与“反对接种”人群间规模和混合程度变化对麻疹负担的影响,以英格兰麻疹为案例,基于预测病例和死亡计算健康、医疗保健、直接医疗成本和生产力损失。

主要发现

  • 高混合水平下,拒绝接种者受益于支持接种人群提供的群体免疫,同时其拒绝增加已接种者(因疫苗不完美)和因其他基础健康状况无法接种者的负担。
  • 上述成本中26%归因于医疗保健成本,74%归因于患者及其照护者的生产力损失。
  • 每次疫苗拒绝对应的社会损失为162.21英镑和0.01(0.006-0.03)个质量调整生命年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing vaccine hesitancy and refusal poses a challenge to public health as even small reductions in vaccine uptake can result in large outbreaks of infectious diseases. Here we estimate the societal costs of vaccine refusal using measles as a case study. METHODS: We developed a compartmental metapopulation model of measles transmission to explore how the changes in the size and level of social mixing between populations that are "pro-vaccination", and "anti-vaccination" impacts the burden of measles. Using the projected cases and deaths, we calculated the health, healthcare, direct medical costs, and productivity loss associated with vaccine refusal. Using measles in England as a case study, we quantified the societal costs that each vaccine refusal imposes on society. FINDINGS: When there is a high level of mixing between the pro- and anti-vaccination populations, those that refuse to be vaccinated benefit from the herd immunity afforded by the pro-vaccination population. At the same time, their refusal to be vaccinated increases the burden in those that are vaccinated due to imperfect vaccines, and in those that are not able to be vaccinated due to other underlying health conditions. Using England as a case study, we estimate that this translates to a societal loss of GBP 292 million and disease burden of 17 630 quality-adjusted-life-years (sensitivity range 10 594-50 379) over a 20-year time horizon. Of these costs, 26 % are attributable to healthcare costs and 74 % to productivity losses for patients and their carers. This translates to a societal loss per vaccine refusal of GBP 162.21 and 0.01 (0.006-0.03) quality-adjusted-life-years. INTERPRETATION: Our findings demonstrate that even low levels of vaccine refusal can have a substantial and measurable societal burden on the population. These estimates can support the value of investment in interventions that address vaccine hesitancy and vaccine refusal, providing not only improved public health but also potential economic benefits to society.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Olivera Mesa D, Winskill P, Ghani AC, et al. The societal cost of vaccine refusal: A modelling study using measles vaccination as a case study. Vaccine. 2023. PMID: 37263873. doi:10.1016/j.vaccine.2023.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。